Vaccines Articles
The Advisory Committee on Immunization Practices (ACIP) approved the Recommended Immunization Schedule for Adults Aged 19 Years or Older for 2014.
New research shows that women have a stronger immune response than men when given the flu vaccine, which may mean vaccinated women are better protected against catching the flu than vaccinated men.
Updates on clinical trials for vaccines against a protein believed to cause Alzheimer's, clostridium difficile and RSV.
A new study conducted by the Centers for Disease Control and Prevention shows that the number of childhood vaccines administered, either in a single day or during the first two years of life, has no bearing on autism risk.
A Canadian study showed that pregnant women who are vaccinated against the flu are significantly less likely to deliver premature or low-birth-weight babies compared with unvaccinated expectant mothers.
A new international study has found that vaccines may prevent the risk of strokes in children.
Updates about SynCon(R) DNA vaccine, melanoma vaccine and Influenza A (H5N1) Virus Monovalent Vaccine, Adjuvanted.
Researchers at the Sealy Center forVaccine Development at the University of Texas Medical Branch (UTMB) at Galveston have developed a safe vaccine candidate for Chagas disease that is simple to produce and shows a greater than 90 percent protection rate against chronic infection in mice.
Collaborating scientists from Nationwide Children’s Hospital, Baylor Institute for Immunology Research and Mount Sinai School of Medicine have identified an important mechanism for stimulating protective immune responses following seasonal influenza vaccinations.
A recent study showed that a universal flu vaccine induced levels of anti-flu antibodies 34 times higher in mice and 10 times higher in ferrets compared with a traditional vaccine.
A study conducted by researchers at the Centers for Disease Control and Prevention found that pregnant women can safely receive the meningococcal vaccine Menactra.
Researchers at Boston Children’s Hospital have identified a potent compound that activates immune responses in newborns’ white blood cells substantially better than anything previously tested, and that could make vaccines effective right after birth.
